Isatuximab plus carfilzomib and dexamethasone in Japanese patients with relapsed multiple myeloma: subgroup analysis of the randomized, open label, phase 3 IKEMA study. (8th September 2022)

Record Type:: Journal Article
Title:: Isatuximab plus carfilzomib and dexamethasone in Japanese patients with relapsed multiple myeloma: subgroup analysis of the randomized, open label, phase 3 IKEMA study. (8th September 2022)
Main Title:: Isatuximab plus carfilzomib and dexamethasone in Japanese patients with relapsed multiple myeloma: subgroup analysis of the randomized, open label, phase 3 IKEMA study
Authors:: Ishida, Tadao
Ito, Shigeki
Tanaka, Junji
Uchiyama, Michihiro
Kawano, Yawara
Moreau, Philippe
Martin, Thomas
Risse, Marie-Laure
Tada, Keisuke
Suzuki, Kenshi
Ishizawa, Kenichi
Abstract:
Is Part Of:: Japanese journal of clinical oncology. Volume 52:Number 12(2022)
Journal:: Japanese journal of clinical oncology
Issue:: Volume 52:Number 12(2022)
Issue Display:: Volume 52, Issue 12 (2022)
Year:: 2022
Volume:: 52
Issue:: 12
Issue Sort Value:: 2022-0052-0012-0000
Page Start:: 1446
Page End:: 1449
Publication Date:: 2022-09-08
Subjects:: Oncology -- Periodicals
Cancer -- Periodicals
616.994005
Journal URLs:: http://jjco.oupjournals.org/ ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/jjco/hyac137 ↗
Languages:: English
ISSNs:: 0368-2811
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 4651.378000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 24606.xml